Iqvia, also known as IQVIA Holdings, is a publicly owned company headquartered in the US. Founded in 1982, it employs approximately 72,660 individuals. The company operates within the Hospitals and Health Care sector, functioning as a global provider of advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry.
Iqvia recently summarized common and challenging questions its market access consulting team answers for customers on July 9, 2026. This initiative focused on activating new levers to expand patient access, improve affordability, and drive brand performance within a complex U.S. healthcare system, particularly in an era of economic compression. Earlier, on July 6, the company detailed pharma launch analytics platforms, explaining how commercial teams utilize prescription claims, payer, and field data for critical targeting, forecasting, and uptake decisions, emphasizing the short six-month window that often sets a new drug's five-year trajectory. This follows an IQVIA Patient-Centered Solutions Industry Forum in London on June 26, where industry leaders explored how patient experience data can deliver measurable impact across development, regulatory, and commercial decision-making amidst growing pressure on clinical development costs.
Subscribe for full access to Iqvia's products in full detail 
